Cargando…
Deregulation of angiopoietin-like 4 slows ovarian cancer progression through vascular endothelial growth factor receptor 2 phosphorylation
BACKGROUND: As a tissue-specific proangiogenic or antiangiogenic agent, angiopoietin-like 4 (ANGPTL4) has recently gained attention in many diseases, such as metabolic syndrome, cardiovascular disease and cancer. However, the roles of ANGPTL4 in angiogenesis and tumor growth in epithelial ovarian ca...
Autores principales: | Wu, Yuxian, Gao, Jinghai, Liu, Xiaojun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968256/ https://www.ncbi.nlm.nih.gov/pubmed/33726754 http://dx.doi.org/10.1186/s12935-021-01865-4 |
Ejemplares similares
-
Knockdown of angiopoietin-like 2 induces clearance of vascular endothelial senescent cells by apoptosis, promotes endothelial repair and slows atherogenesis in mice
por: Caland, Laurie, et al.
Publicado: (2019) -
Vascular endothelial growth factors and angiopoietins as new players in mastocytosis
por: Marcella, Simone, et al.
Publicado: (2021) -
Involvement of Angiopoietin 2 and vascular endothelial growth factor in uveitis
por: Suzuki, Kayo, et al.
Publicado: (2023) -
Angiopoietin-like 3 inhibition of endothelial lipase is not modulated by angiopoietin-like 8
por: Sylvers-Davie, Kelli L., et al.
Publicado: (2021) -
Prognostic role of plasma level of angiopoietin-1, angiopoietin-2, and vascular endothelial growth factor in hepatocellular carcinoma
por: Choi, Gwang Hyeon, et al.
Publicado: (2021)